On the filings, Vertex (VRTX) is the stronger stock right now — higher on our blended fundamentals-plus-verdict read, and we currently rate it HOLD.
Balance-sheet-strong turnaround with revenue finally stabilizing, but falling earnings and a full its multiple leave no margin of safety.
Fortress-balance-sheet biotech finally diversifying past cystic fibrosis, but ~its multiple on ~9% growth fairly prices the quality.
| Metric | BIIB | VRTX |
|---|---|---|
| Fundamentals score | 66 | 86 |
| Revenue growth (YoY) | +2.2% | +8.9% |
| Net income growth (YoY) | -20.8% | +838.1% |
| Net margin | 13.1% | 32.9% |
| Return on equity | 7.1% | 21.2% |
| ROIC (est.) | 9.1% | 17.7% |
| Liabilities / Equity | 0.61 | 0.37 |
| Piotroski F-score | 5 / 9 | 5 / 9 |
Bold green = the stronger figure. All rows derive from SEC XBRL filings — no market-price data on this page.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 2, 2026, 9:51 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 19, 2026, 2:25 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.